(Image Source: ALAMY)

 

BY XIAONAN WANG

ANCHOR CHRISTIAN BRYANT

Major progress in breast cancer research: U.K. scientists have identified 10 subtypes of this disease. A researcher tells Channel 4 News why it matters.

“It’s a big step toward this idea of tailoring disease treatment to every individual, this idea of personalized... in this case toward breast cancer.”

One author of the report explains why targeted treatment might make for a more effective outcome. Daily Mail has the details.

“‘That will enable us to make sure that we really target the right treatment to the right woman based on those who are going to benefit, or if they’re not going to benefit, not exposing them to the side-effects associated with those treatments.”

The study might also lead to better diagnosis and prognosis of breast cancer. A researcher explains to Telegraph:  
“...we now have identified a number of genes that are responsible for driving breast cancers in some way that we didn’t previously know about.”

The discovery of how genetics influences breast cancer may also revive some “trash-can” drugs. Bloomberg has the details from an expert.

“It’s likely that a lot of drugs have been thrown out by pharmaceutical companies that would benefit small groups of patients.”

BBC says it still takes some time before the findings can actually go from the lab into real life.

“The researchers need to prove that the 10 classifications actually provide any benefit to people with breast cancer, before they can be used by doctors...That process is expected to take three to five years.”

National Cancer Institute estimates about 226,000 women in the U.S. will be diagnosed with breast cancer and about 40,000 will die. Also, about 22-hundred men will be diagnosed with breast cancer and 410 will die each year.

New Breast Cancer Research Promises Better Treatment

by
0
Transcript
Apr 20, 2012

New Breast Cancer Research Promises Better Treatment

(Image Source: ALAMY)

 

BY XIAONAN WANG

ANCHOR CHRISTIAN BRYANT

Major progress in breast cancer research: U.K. scientists have identified 10 subtypes of this disease. A researcher tells Channel 4 News why it matters.

“It’s a big step toward this idea of tailoring disease treatment to every individual, this idea of personalized... in this case toward breast cancer.”

One author of the report explains why targeted treatment might make for a more effective outcome. Daily Mail has the details.

“‘That will enable us to make sure that we really target the right treatment to the right woman based on those who are going to benefit, or if they’re not going to benefit, not exposing them to the side-effects associated with those treatments.”

The study might also lead to better diagnosis and prognosis of breast cancer. A researcher explains to Telegraph:  
“...we now have identified a number of genes that are responsible for driving breast cancers in some way that we didn’t previously know about.”

The discovery of how genetics influences breast cancer may also revive some “trash-can” drugs. Bloomberg has the details from an expert.

“It’s likely that a lot of drugs have been thrown out by pharmaceutical companies that would benefit small groups of patients.”

BBC says it still takes some time before the findings can actually go from the lab into real life.

“The researchers need to prove that the 10 classifications actually provide any benefit to people with breast cancer, before they can be used by doctors...That process is expected to take three to five years.”

National Cancer Institute estimates about 226,000 women in the U.S. will be diagnosed with breast cancer and about 40,000 will die. Also, about 22-hundred men will be diagnosed with breast cancer and 410 will die each year.

View More
Comments
Newsy
www2